Aurora Cannabis Stock Trims Losses, Tops Estimates

Aurora Cannabis (TSX:ACB)(NYSE:ACB) stock trimmed losses to $75.5 million, but problems still remain for this international cannabis producer.

| More on:
Cannabis stocks have fallen.

Aurora Cannabis (TSX:ACB)(NYSE:ACB) reported a loss of $75.1 million for the second quarter, with the cannabis company’s growth outlook shaky, as it attempts to expand in international markets.

  • Aurora Cannabis stock reported a loss of $75.1 million, with net revenue falling 48% year over year.
  • Adjusted EBITDA improved by 22% year over year to a loss of $9 million.
  • Consumer cannabis fell to $14.8 million, while global medical cannabis net revenue increased 18% year over year.

What happened in Q2 for Aurora Cannabis stock?

Aurora Cannabis stock had some positive and negative news for the quarter for investors. On the one hand, net revenue for consumer cannabis fell by 48% year over year. However, global medical cannabis net revenue increased by 18% year over year. And while the company’s loss amounted to $0.38 per share, it was a huge improvement from a loss of $1.77 the year before.

Net revenue for the quarter came in at $60.6 million for the quarter, down 10% from $67.6 million the year before. However, even the loss of $75.5 million was good news, and Aurora Cannabis stock improved its position of a loss of $279.9 million the year before.

What did Aurora Cannabis management say?

Management noted Aurora Cannabis stock improved its adjusted EBITDA by $2.5 million quarter over quarter. This brings it one step closer to its goal of becoming profitable. It’s similar to many other large cannabis producers with a focus on cost cuts, and it has $445 million in cash on the books.

“Q2 total cannabis net revenue held steady sequentially, driven by our industry leading, high margin global medical cannabis business. New international markets are rapidly opening, and with the unique ability to navigate complex regulatory environments, we see a significant revenue opportunity of which we are at the forefront. While the Canadian adult-use market continues to face challenges, we are focused on introducing a new range of products set to launch this spring.”

Miguel Martin, chief executive officer of Aurora Cannabis

What’s next for Aurora Cannabis stock?

There are a lot of “ifs” surrounding Aurora Cannabis stock. The biggest is the expansion in the international market. While there is a lot of potential in countries like Israel, Australia, and Europe, the wave of cannabis legalization will have to continue for Aurora Cannabis to continue growing.

Meanwhile, the company expects to reach the high end of its $60-$80 million range. Further, with so much cash on the books, it’s seeking our merger and acquisition opportunities. Yet analysts weren’t so convinced on Friday morning, stating international opportunities aren’t a sure thing.

While analysts continue to like Aurora Cannabis stock’s margins, the growth outlook isn’t as solid. For now, Aurora may be expecting too much growth far too soon.

Shares of Aurora Cannabis stock are down 67% in the last year and up 24% in the last month.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Amy Legate-Wolfe owns Aurora Cannabis. The Motley Fool has no position in any of the stocks mentioned.

More on Cannabis Stocks

A person holds a small glass jar of marijuana.
Cannabis Stocks

Cannabis Stocks Jump: What Investors Need to Know

Cannabis stocks have started to recover in recent weeks, showing there might be signs that now is the time to…

Read more »

A cannabis plant grows.
Cannabis Stocks

$1,000 Invested in Aurora Cannabis Stock at the Start of 2022 Would Be Worth This Much Today

Aurora Cannabis is a fundamentally weak cannabis stock which is trading 98% below all-time highs. Is ACB an undervalued stock…

Read more »

A cannabis plant grows.
Cannabis Stocks

Why Canopy Growth Stock (TSX:WEED) Fell 23% in September

Canopy Growth stock's downfall continues as financial losses combined with a deteriorating macro environment take a heavy toll. Is there…

Read more »

Upwards momentum
Energy Stocks

3 Canadian Stocks That Could be Huge Winners in the Next Decade and Beyond

Stocks like Canopy Growth, Blackberry, and Ballard Power are leading and redefining new multi-billion dollar industries.

Read more »

A cannabis plant grows.
Cannabis Stocks

Should You Invest in Canadian Cannabis Stocks Like Canopy Growth in September?

Canadian cannabis stocks, including Canopy Growth, remain high-risk bets for investors, despite trading 94% below all-time highs.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

ACB Stock: What’s Behind Aurora Cannabis’ Recent Surge?

More countries are legalizing marijuana. Should you buy ACB stock?

Read more »

data analytics, chart and graph icons with female hands typing on laptop in background
Cannabis Stocks

Got $5,000? 3 Stocks to Hold for the Next 20 Years

Long-term investors can consider buying shares of Dollarama and Curaleaf to generate market-beating gains in the next two decades.

Read more »

A cannabis plant grows.
Cannabis Stocks

Is Now the Time to Buy Cannabis Stocks?

These cannabis stocks are up 70% and 19% this month! Should Canadian investors hop on board?

Read more »